Search clinical trials for: Ovarian hyperstimulation syndrome (OHSS)

Total 41842 results

Regionshospitalet Viborg, Skive

Completed

Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

OHSS (Ovarian Hyperstimulation)

Denmark
Instituto de Investigacion Sanitaria La Fe

Unknown

Prediction of High Ovarian Response After Assisted Reproductive Techniques (HighART)

PCOS | OHSS

Spain
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Cabergoline Reduces OHSS

Ovarian Hyperstimulation Syndrome
Mona M Shaban

Unknown

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS (OHSS)

Ovarian Hyperstimulation Syndrome

Egypt
The Affiliated Hospital of Inner Mongolia Medical...

Not yet recruiting

The Letrozole Administration During Luteal Phase

Ovarian Hyperstimulation Syndrome

China
Royan Institute

Completed

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
Ganin Fertility Center

Completed

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Ovarian Hyperstimulation Syndrome

Egypt
Centre for Endocrinology and Reproductive Medicine...

Completed

Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)

PCOS | INFERTILITY | OHSS

Italy
Benha University

Completed

Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

Infertility

Egypt
University Hospital Schleswig-Holstein

Completed

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

Ovarian Hyperstimulation Syndrome

Germany
Cairo University

Completed

Calcium for Prevention of Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome

Egypt
Benha University
Hawaa Fertility Center

Suspended

Montelukast for Prevention & Treatment of OHSS

Ovarian Hyperstimulation Syndrome

Egypt
Mansoura University

Completed

LOD Before IVF/ICSI in PCOS Patients With High AMH

Infertility | Polycystic Ovarian Syndrome

Egypt
Cairo University

Completed

Cabergoline and Coasting to Prevent OHSS (OHSS)

OHSS

Egypt
Eugonia

Unknown

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome

Greece
KK Women's and Children's Hospital

Completed

Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers

Ovarian Hyperstimulation Syndrome

Singapore
Benha University

Completed

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (infertility)

Infertility

Egypt
Eugonia

Unknown

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Greece
Universitair Ziekenhuis Brussel

Completed

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (ICE)

Infertility | OHSS

Belgium
Al-Azhar University

Not yet recruiting

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

Ovarian Hyperstimulation Syndrome
Iakentro Fertility Centre
Aristotle University Of Thessaloniki

Completed

Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS

Ovarian Hyperstimulation Syndrome
IVI Madrid

Completed

Resveratrol as a Preventive Treatment of OHSS (RES-OHSS)

Infertility

Spain
Aljazeera Hospital

Completed

Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome

OHSS

Egypt
First Affiliated Hospital, Sun Yat-Sen University

Unknown

Preventive Application of GnRH Antagonist on Early OHSS

Ovarian Hyperstimulation Syndrome | GnRH Antagonist | Aspirin | Vascular Endothelial Growth Factor | Pigment Epithelium Derived Factor

China
Aljazeera Hospital

Unknown

Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

OHSS

Egypt
Antalya IVF

Withdrawn

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

Pregnancy | Ovarian Hyperstimulation Syndrome

Turkey
First Affiliated Hospital, Sun Yat-Sen University

Completed

Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

Ovarian Hyperstimulation Syndrome
UConn Health
Merck Sharp & Dohme LLC

Completed

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
Bioroma

Unknown

Long Acting GnRH Antagonist in PCOS Women Undergoing IVF

Ovarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome | Invitro Fertilization

Italy
Sun Yat-sen University

Unknown

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome

China
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

Ovarian Hyperstimulation Syndrome | Effects of Gonadotropin | Oocyte Maturation

Spain
Zekai Tahir Burak Women's Health Research and Education...

Completed

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Polycystic Ovary Syndrome

Turkey
IVI Madrid

Completed

Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

Vascular Endothelial Growth Factor Overexpression
ClinAmygate
Cairo University; Al-Azhar University; Beni-Suef University

Completed

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Ovarian Hyperstimulation Syndrome

Egypt
University of Connecticut
Organon

Completed

The Use of GnRH Agonist Trigger in the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
Nanjing University

Unknown

GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

Infertile High-risk Patients With Polycystic Ovaries

China
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
Shin Kong Wu Ho-Su Memorial Hospital

Completed

The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation

In Vitro Fertilization

Taiwan
Universitair Ziekenhuis Brussel
Merck Serono International SA

Unknown

Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)

Pregnancy | Embryonic Development | VEGF

Belgium
Meir Medical Center

Unknown

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

Infertility
Al Baraka Fertility Hospital

Recruiting

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

IVF

Bahrain
Merck KGaA, Darmstadt, Germany

Terminated

Low-dose Gonal-f® in Ovulation Induction (LoGo)

Infertility | Monofollicular Development

United Kingdom, Ireland
Sheba Medical Center

Unknown

Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF

Infertility

Israel
Institut Universitari Dexeus

Terminated

Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1

Polycystic Ovary Syndrome | In Vitro Fertilization

Spain
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
IVI Madrid

Completed

Endometrial Receptivity After GnRH Agonist Triggering (ERAMAD)

Ovarian Hyperstimulation Syndrome

Spain
Ferring Pharmaceuticals

Completed

Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. (SHOview)

Ovarian Hyperstimulation Syndrome (OHSS)

France
Wolfson Medical Center

Withdrawn

Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)

Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)
Peter Hornnes, MD, DMSc

Completed

Short Versus Long Protocol for IVF and IVF+ICSI (KvL)

Quality of Life | Infertility | Ovarian Hyperstimulation Syndrome | Live Birth

Denmark
Virginia Center for Reproductive Medicine

Completed

The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors

Ovarian Hyperstimulation Syndrome

United States

Search clinical trials for: Ovarian hyperstimulation syndrome (OHSS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations